One of the most common challenges for people with diabetes is trying to prevent blood sugars from shooting up after meals. Drs. E and P have been managing spikes for over 75 years between the two of ’em, and they offer clear-cut suggestions on how to keep post-meal highs at bay.
read more →
Dr. Edelman discusses the important role ACE inhibitors and ARBs play in protecting your heart and kidneys.
read more →
We are fortunate to have many medications today to treat type 2 diabetes. Beyond improving glucose levels, some of these medications also have beneficial effects on other conditions that are common in people with type 2, such as heart failure and diabetic kidney disease.
read more →
Dr. Edelman clarifies how SGLTs and GLP-1s affect insulin use, and whether or not they cause hypoglycemia.
read more →
Our international panel of diabetes experts discussed highlights from the ADA’s Scientific Sessions, and lead a Q&A on some of the most important advances in diabetes.
read more →
With newer medication options available now for treating type 2 diabetes, Dr. Edelman answers a common question about how they can be included in a diabetes management regimen with regard to metformin.
read more →
Jeremy Pettus explains the pros and cons of SGLT2s for people with type 1, and offers advice on how to try them safely and smartly.
read more →
SGLT2s are currently only approved for use in the U.S. for type 2 diabetes, but a lot of people with type 1 are taking them off label with positive results.
read more →
The newest classes of diabetes meds to treat type 2 are pulling more than double duty, helping to better control blood sugars, protect the heart, lower body weight and prevent chronic kidney disease.
read more →
SGLT-2 Inhibitors including Invokana (canagliflozin), Farxiga (dapagliflozin), Jardiance (empagliflozin) and Steglatro (ertugliflizin), are the newest class of oral medications for the treatment of type 2 diabetes. They’re generally well tolerated and associated with significant weight loss compared with other type 2 oral meds, but there are still precautions to consider.
read more →
